Selectis Health (GBCS) Common Equity (2011 - 2025)

Selectis Health (GBCS) has 15 years of Common Equity data on file, last reported at -$6.2 million in Q4 2025.

• Quarterly Common Equity fell 14.79% year-over-year to -$6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.2 million (down 14.79% YoY) and the FY2025 annual result came in at -$6.2 million, down 14.79% from the prior year.
• Common Equity slipped to -$6.2 million in Q4 2025 per GBCS's latest filing, from -$5.7 million in the prior quarter.
• The five-year high for Common Equity was $5.0 million in Q1 2023, with the low at -$6.4 million in Q2 2025.
• Average Common Equity over 5 years is -$591118.8, with a median of $814799.0 recorded in 2022.
• Year-over-year, Common Equity soared 684.92% in 2021 and slumped 814.25% in 2024.
• Selectis Health's Common Equity stood at $3.1 million in 2021, then slumped by 69.29% to $952835.0 in 2022, then sank by 411.05% to -$3.0 million in 2023, then slumped by 82.54% to -$5.4 million in 2024, then retreated by 14.79% to -$6.2 million in 2025.
• Business Quant data shows GBCS's Common Equity at -$6.2 million in Q4 2025, -$5.7 million in Q3 2025, and -$6.4 million in Q2 2025.